COVID-19 Rapid Antigen Test from MoLab - Box of 200 Tests with 200 Individual Buffer Solution - CE-IVD Certified
A Point-Of-Care Covid-19 antigen test that reveals if a person is currently infected with SARS-CoV-2 virus.
Ireland - 24/48hrs via courier
UK - 48/72hrs via courier
For volume/discounted pricing and EU orders please contact us at email@example.com
The mo-screen Corona Antigen Cassette is a rapid in vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen.
Delivery to Ireland and UK.
For bulk/wholesale pricing please contact us at firstname.lastname@example.org
The box includes 200 individually sealed cartridges, along with:
- 200 sterile swabs
- 200 extraction Tubes
- 200 dropper tips for extraction tubes
- 200 individual buffer solution (0,09 % sodium azide)
- 20 workstation
- 1 instruction manual (IFU)
Duration: A qualitative result can be read after 15 minutes
Shelf life: 24 months
Certification: European CE Marking for In Vitro Diagnostic (IVD) devices
The two main antigens for coronavirus SARS-CoV-2 are the spike (S) protein and the nucleocapsid (N) protein. The nucleocapsid protein has emerged as a better target for diagnostic antigen tests because it's more conserved, and it's more abundant.
Unlike many tests out there, MöLab COVID-19 Rapid Antigen Test detects the nucleocapsid protein making it a far more accurate and dependable test
MoLab GmbH was established in 1983. For more than 37 years, the company has been pioneering new and modern ways to manufacture point-of-care diagnostics in Germany. Their products and services serve doctors, hospitals, utilities, public institutions, and security-related authorities all across Europe.
MyBio have undertaken extensive research in order to find a rapid test of this accuracy and more importantly, reliability. Please read our research white paper on how rapid antigen testing can play a role in opening up Ireland and ending the cycle of lockdowns.
COVID, COVID-19, CoV2, CoV-2, Corona, nCoV, SARS-CoV, SARS-CoV-2